公司資料
Alterity Therapeutics 股價、新聞與催化劑
- 股票代碼:
- ATHE
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Australia and listed in the U
股票表現
3.75 USD (-2.60%)
收盤價
最後更新: 2026年9月17日
1.46M USD
市值
股價為何變動
截至 2026年9月17日，ATHE 下跌 2.60%，收於 $3.75。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Alterity Therapeutics is a neuroscience company focused on neurodegenerative disease, especially disorders with alpha-synuclein pathology. Its story is built around trying to address difficult CNS diseases through disease-modifying biology.
所在地與產業分類
Alterity is headquartered in Australia and listed in the U.S. market. It sits in small-cap neuroscience biotechnology.
商業模式特徵
The company depends on translational validation, clinical progress, and capital support. Investors usually watch early data and whether the biology can create a compelling neurodegeneration thesis.
生技產業定位
Alterity occupies a specialized neurodegeneration niche within biotech. It is catalyst-sensitive because the market needs evidence that the platform can matter in CNS disease.
未來催化劑
- Alterity’s catalysts are ATH434 and the neurodegeneration / iron-biology story, with any clinical update that can re-rate the name quickly. The company is still very much a proof-of-concept story.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。